SHJ-002

N/A

Report date: 2022/08/06 20:00:36
NME

Base Information

Drug NameSHJ-002
Drug Alias NameSHJ-002
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMicroRNAs inhibitors
TargetsMicroRNAs
Therapy Area/IndicationsMyopia, DegenerativeMyopiaDry Eye Syndromes +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanThailand +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSunhawk Vision Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesDreamhawk Vision Biotech IncSunhawk Vision Biotech Inc
Inactive CompaniesN/A
Active IndicationsMyopia, DegenerativeMyopiaDry Eye Syndromes +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A